相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fractionated stereotactic radiosurgery for the treatment of meningiomas
Carley Bria et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2011)
Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
Sylwia Ammoun et al.
NATURE REVIEWS NEUROLOGY (2011)
Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2
Sylwia Ammoun et al.
NEURO-ONCOLOGY (2011)
Middle Fossa Decompression for Hearing Preservation: A Review of Institutional Results and Indications
William H. Slattery et al.
OTOLOGY & NEUROTOLOGY (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
A Meningioma Exclusively Located inside the Superior Sagittal Sinus Responsible for Intracranial Hypertension
B. Szitkar
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation
V. -F. Mautner et al.
ANNALS OF ONCOLOGY (2010)
Anti-Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Hon Kit Wong et al.
CANCER RESEARCH (2010)
Neuroblastoma: Therapeutic strategies for a clinical enigma
Shakeel Modak et al.
CANCER TREATMENT REVIEWS (2010)
Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
Wei Li et al.
CELL (2010)
The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36
W. J. Neary et al.
CLINICAL OTOLARYNGOLOGY (2010)
Merlin, a Magic Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Ivan Stamenkovic et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2
W. J. Neary et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2010)
Meningiomas and neurofibromatosis
Stephane Goutagny et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The Novel Hsp90 Inhibitor NXD30001 Induces Tumor Regression in a Genetically Engineered Mouse Model of Glioblastoma Multiforme
Haihao Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner et al.
NEURO-ONCOLOGY (2010)
ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma
Sylwia Ammoun et al.
NEURO-ONCOLOGY (2010)
Perioperative and Long-term Outcomes From the Management of Parasagittal Meningiomas Invading the Superior Sagittal Sinus
Shaan M. Raza et al.
NEUROSURGERY (2010)
Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas
K. D. Hadfield et al.
ONCOGENE (2010)
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
Scott R. Plotkin et al.
OTOLOGY & NEUROTOLOGY (2010)
Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2
Patrice Tran Ba Huy et al.
ACTA OTO-LARYNGOLOGICA (2009)
The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells
Mizuho Nonaka et al.
CANCER CELL INTERNATIONAL (2009)
Biomarker-Driven Early Clinical Trials in Oncology A Paradigm Shift in Drug Development
Daniel S. W. Tan et al.
CANCER JOURNAL (2009)
Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2
D. Gareth Evans et al.
CLINICAL CANCER RESEARCH (2009)
The Association Between Hearing Status and Psychosocial Health Before the Age of 70 Years: Results From an Internet-Based National Survey on Hearing
Janneke Nachtegaal et al.
EAR AND HEARING (2009)
Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
Tina X. Lee et al.
EUROPEAN JOURNAL OF CANCER (2009)
BEVACIZUMAB AS THERAPY FOR RADIATION NECROSIS IN FOUR CHILDREN WITH PONTINE GLIOMAS
Arthur K. Liu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
CLINICAL EXPERIENCE WITH RADIATION THERAPY IN THE MANAGEMENT OF NEUROFIBROMATOSIS-ASSOCIATED CENTRAL NERVOUS SYSTEM TUMORS
Stacy Wentworth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study
Jaishri O. Blakeley et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma
Scott R. Plotkin et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
WHO grade II and III meningiomas: a study of prognostic factors
Anne Durand et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Intracranial Meningiomatosis Causing Foster Kennedy Syndrome by Unilateral Optic Nerve Compression and Blockage of the Superior Sagittal Sinus
X. Acebes et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2009)
Stereotactic radiosurgery for convexity meningiomas Clinical article
Douglas Kondziolka et al.
JOURNAL OF NEUROSURGERY (2009)
Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
Miguel A. Lopez-Lago et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
Marianne F. James et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Neurofibromatosis type 2
Ashok R. Asthagiri et al.
LANCET (2009)
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2009)
VESTIBULAR SCHWANNOMA: SURGERY OR GAMMA KNIFE RADIOSURGERY? A PROSPECTIVE, NONRANDOMIZED STUDY
Erling Myrseth et al.
NEUROSURGERY (2009)
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Scott R. Plotkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Neurofibromatosis type 2 (NF2): A clinical and molecular review
D. Gareth R. Evans
ORPHANET JOURNAL OF RARE DISEASES (2009)
Concordance of Bilateral Vestibular Schwannoma Growth and Hearing Changes in Neurofibromatosis 2: Neurofibromatosis 2 Natural History Consortium
Laurel M. Fisher et al.
OTOLOGY & NEUROTOLOGY (2009)
Objective Response of Multiply Recurrent Low-Grade Gliomas to Bevacizumab and Irinotecan
Roger J. Packer et al.
PEDIATRIC BLOOD & CANCER (2009)
Merlin and the ERM proteins - regulators of receptor distribution and signaling at the cell cortex
Andrea I. McClatchey et al.
TRENDS IN CELL BIOLOGY (2009)
Hearing rehabilitation in neurofibromatosis type 2 patients: Cochlear versus auditory brainstem implantation
Vincenzo Vincenti et al.
AUDIOLOGY AND NEURO-OTOLOGY (2008)
Designing phase 0 cancer clinical trials
Anthony J. Murgo et al.
CLINICAL CANCER RESEARCH (2008)
The relationship between changes in self-rated quality of life after cochlear implantation and changes in individual complaints
F. Zhao et al.
CLINICAL OTOLARYNGOLOGY (2008)
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A children's oncology group study
Julia L. Glade Bender et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II
Gordon J. Harris et al.
NEUROSURGERY (2008)
Translabyrinthine approach for acoustic tumor removal (Reprinted from Otolaryngologic Clinics of NA vol 25, pg 311-330, 1992)
Derald E. Brackmann et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2008)
Surgical approaches and complications in the removal of vestibular schwannomas (Reprinted from Otolaryngologic Clinics of NA, vol 40)
Marc Bennett et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2008)
Auditory brainstem implants
Marc S. Schwartz et al.
NEUROTHERAPEUTICS (2008)
Idiopathic sudden sensorineural hearing loss
Steven D. Rauch
NEW ENGLAND JOURNAL OF MEDICINE (2008)
ErbB and Nrg: Potential molecular targets for vestibular schwannoma pharmacotherapy
Joni K. Doherty et al.
OTOLOGY & NEUROTOLOGY (2008)
Auditory Brainstem implant in Neurofibromatosis Type 2 and Non-Neurofibromatosis Type 2 Patients
Alexis Bozorg Grayeli et al.
OTOLOGY & NEUROTOLOGY (2008)
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
Kristian Pietras et al.
PLOS MEDICINE (2008)
Compassionate use of bevacizumab (Avastin®) in children and young adults with refractory or recurrent solid tumors
M. Benesch et al.
ANNALS OF ONCOLOGY (2008)
Nf2/Merlin: a coordinator of receptor signalling and intercellular contact
M. Curto et al.
BRITISH JOURNAL OF CANCER (2008)
Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature
Anandh Balasubramaniam et al.
NEURO-ONCOLOGY (2007)
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
Marcello Curto et al.
JOURNAL OF CELL BIOLOGY (2007)
Cochlear implantation in the neurofibromatosis type 2 patient: Long-term follow-up
Brian A. Neff et al.
LARYNGOSCOPE (2007)
Facial nerve function after translabyrinthine vestibular schwannoma surgery
Derald E. Brackmann et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
Shedding light on Merlin's wizardry
Tomoyo Okada et al.
TRENDS IN CELL BIOLOGY (2007)
Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications, and hearing preservation rates
David Mathieu et al.
NEUROSURGERY (2007)
Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac
Helen Morrison et al.
CANCER RESEARCH (2007)
Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses
Marc P. Sindou et al.
JOURNAL OF NEUROSURGERY (2006)
Cochlear implantation in patients with neurofibromatosis Type 2 and bilateral vestibular schwannoma
Lawrence R. Lustig et al.
OTOLOGY & NEUROTOLOGY (2006)
Using audiometric thresholds and word recognition in a treatment study
C Halpin et al.
OTOLOGY & NEUROTOLOGY (2006)
Tailoring Ras-pathway - Inhibitor combinations for cancer therapy
R Blum et al.
DRUG RESISTANCE UPDATES (2005)
Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin
AI McClatchey et al.
GENES & DEVELOPMENT (2005)
The accuracy of meningioma grading: a 10-year retrospective audit
J Willis et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Resection of large vestibular schwannomas: facial nerve preservation in the context of surgical approach and patient-assessed outcome
DE Anderson et al.
JOURNAL OF NEUROSURGERY (2005)
Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: A study of 24 patients
M Ruggieri et al.
NEUROPEDIATRICS (2005)
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: Higher incidence than previously thought
DGR Evans et al.
OTOLOGY & NEUROTOLOGY (2005)
Translabyrinthine approach for acoustic neuroma
JD Day et al.
NEUROSURGERY (2004)
Vestibular schwannoma growth rates in Neurofibromatosis type 2 Natural History consortium subjects
WH Slattery et al.
OTOLOGY & NEUROTOLOGY (2004)
Long-term hearing preservation after middle fossa removal of vestibular schwannoma
RA Friedman et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2003)
Neurofibromatosis 2 in the pediatric population
F Nunes et al.
JOURNAL OF CHILD NEUROLOGY (2003)
The natural history of incidental meningiomas
M Nakamura et al.
NEUROSURGERY (2003)
Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas
JG Rowe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Predictors of the risk of mortality in neurofibromatosis 2
ME Baser et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas
JYK Lee et al.
JOURNAL OF NEUROSURGERY (2002)
The Raf/MEK/ERK pathway:: new concepts of activation
C Peyssonnaux et al.
BIOLOGY OF THE CELL (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
